Literature DB >> 10365793

Biodistribution of filamentous phage-Fab in nude mice.

Y L Yip1, N J Hawkins, G Smith, R L Ward.   

Abstract

In vivo panning of peptide libraries in mice has allowed the isolation of peptides which target the vasculature of specific organs. The application of this approach to phage displaying Fab fragments (phage-Fab) could lead to the isolation of antibodies which recognize novel tumor antigens. In this study, we have evaluated the biodistribution of phage-Fab in nude mice. Balb/c nude mice were injected intravenously with 10(9) TU of phage displaying the anti-colon cancer Fab c30.6. Blood samples were collected at nine time points over a period of 72 h and three groups of four mice were sacrificed at 4 min, 24 h and 72 h. Normal tissues (liver, colon, spleen, kidneys, lungs, skeletal muscle) and faeces were collected at these time points and the number of viable phage in each sample was determined. The distribution of phage in tissues was also examined by immunohistochemical analysis of paraffin-embedded tissues. Regression analysis of plasma kinetic data showed that the half-life and the volume of distribution of phage was 3.6 h and 1 ml, respectively. Phage uptake occurred predominantly in lungs, kidneys, spleen and liver. Relatively few phage were distributed to colon and muscle, and phage were eliminated from the circulation by 72 h. Immunohistochemical analysis showed phage to be mainly within the vasculature at 4 min, whereas notable phage extravasation was observed at 24 h and 72 h. In conclusion, this study provides information on the in vivo behavior of phage-Fab which will be useful in the design of in vivo panning strategies. By choosing appropriate time points for tissue collection, it may be possible to isolate novel Fabs against both intra- and extravascular targets.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365793     DOI: 10.1016/s0022-1759(99)00044-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid.

Authors:  Ana Maria Gonzalez; Wendy Leadbeater; Sonia Podvin; Alexandra Borboa; Michael Burg; Ritsuko Sawada; James Rayner; Karen Sims; Tetsuya Terasaki; Conrad Johanson; Edward Stopa; Brian Eliceiri; Andrew Baird
Journal:  Brain Res       Date:  2010-08-21       Impact factor: 3.252

2.  Pseudovirions as vehicles for the delivery of siRNA.

Authors:  Paul E Lund; Ryan C Hunt; Michael M Gottesman; Chava Kimchi-Sarfaty
Journal:  Pharm Res       Date:  2009-12-09       Impact factor: 4.200

3.  Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display.

Authors:  Andrew Baird; Brian P Eliceiri; Ana Maria Gonzalez; Conrad E Johanson; Wendy Leadbeater; Edward G Stopa
Journal:  Methods Mol Biol       Date:  2011

4.  Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies.

Authors:  David Sánchez-Martín; Jorge Martínez-Torrecuadrada; Tambet Teesalu; Kazuki N Sugahara; Ana Alvarez-Cienfuegos; Pilar Ximénez-Embún; Rodrigo Fernández-Periáñez; M Teresa Martín; Irene Molina-Privado; Isabel Ruppen-Cañás; Ana Blanco-Toribio; Marta Cañamero; Angel M Cuesta; Marta Compte; Leonor Kremer; Carmen Bellas; Vanesa Alonso-Camino; Irene Guijarro-Muñoz; Laura Sanz; Erkki Ruoslahti; Luis Alvarez-Vallina
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

5.  Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies.

Authors:  Girja S Shukla; David N Krag; Elena N Peletskaya; Stephanie C Pero; Yu-Jing Sun; Chelsea L Carman; Laurence E McCahill; Thomas A Roland
Journal:  Cancer Immunol Immunother       Date:  2013-06-05       Impact factor: 6.968

6.  Biodistribution of filamentous phage peptide libraries in mice.

Authors:  Jun Zou; Marie T Dickerson; Nellie K Owen; Linda A Landon; Susan L Deutscher
Journal:  Mol Biol Rep       Date:  2004-06       Impact factor: 2.316

7.  Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system.

Authors:  Ana Maria Gonzalez; Wendy E Leadbeater; Michael Burg; Karen Sims; Tetsuya Terasaki; Conrad E Johanson; Edward G Stopa; Brian P Eliceiri; Andrew Baird
Journal:  BMC Neurosci       Date:  2011-01-07       Impact factor: 3.288

8.  An in vivo approach to structure activity relationship analysis of peptide ligands.

Authors:  Xiaomin Fan; Ruben Venegas; Robert Fey; Henri van der Heyde; Mark A Bernard; Elias Lazarides; Catherine M Woods
Journal:  Pharm Res       Date:  2007-03-22       Impact factor: 4.580

Review 9.  Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies.

Authors:  Rossella Sartorius; Luciana D'Apice; Antonella Prisco; Piergiuseppe De Berardinis
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321

Review 10.  Plant/Bacterial Virus-Based Drug Discovery, Drug Delivery, and Therapeutics.

Authors:  Esen Sokullu; Hoda Soleymani Abyaneh; Marc A Gauthier
Journal:  Pharmaceutics       Date:  2019-05-03       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.